CEL-SCI CORPORATION Shareholders' Equity
CEL-SCI CORPORATION (CVM) had Shareholders' Equity of $10.96 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $10.96M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.87M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $11.14M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $15.96M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $10.96M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.87M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $11.14M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $15.96M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $7.02M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $8.00M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $11.31M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $12.87M 10-Q · filed 2026-08-14 | |
| 2024-06-30 | $8.47M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $14.30M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $12.65M 10-Q · filed 2025-08-14 | |
| 2023-09-30 | $13.21M 10-K · filed 2025-12-29 | |
| 2023-06-30 | $14.79M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $20.15M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $26.59M 10-Q · filed 2024-08-14 | |
| 2022-09-30 | $32.16M 10-K · filed 2025-01-13 | |
| 2022-06-30 | $38.73M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $45.13M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $51.35M 10-Q · filed 2023-08-10 | |
| 2021-10-01 | $56.53M 10-Q · filed 2022-05-13 | |
| 2021-09-30 | $56.53M 10-K · filed 2023-12-21 | |
| 2021-06-30 | $59.79M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $29.33M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $28.84M 10-Q · filed 2022-08-12 | |
| 2020-10-01 | $19.73M 10-Q · filed 2022-05-13 | |
| 2020-09-30 | $19.73M 10-K · filed 2022-12-27 | |
| 2020-06-30 | $20.89M 10-Q · filed 2021-08-13 | $19.01M 10-Q/A · filed 2020-08-11 |
| 2020-03-31 | $14.14M 10-Q · filed 2021-08-13 | $12.21M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $8.95M 10-Q · filed 2021-08-13 | $6.97M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $5.13M 10-K · filed 2021-12-21 | |
| 2019-06-30 | $1.15M 10-Q/A · filed 2020-12-31 | |
| 2019-03-31 | $955.52K 10-Q/A · filed 2020-12-31 | |
| 2018-12-31 | $2.71M 10-Q/A · filed 2020-12-31 | |
| 2018-09-30 | $916.00 10-Q/A · filed 2020-12-31 | |
| 2018-06-30 | -$1.25M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | -$3.06M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | -$4.83M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | -$3.34M 10-K/A · filed 2019-12-23 | |
| 2017-06-30 | -$5.08M 10-Q/A · filed 2017-12-11 | -$5.31M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$2.83M 10-Q/A · filed 2017-12-11 | -$3.08M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.69M 10-Q/A · filed 2017-12-11 | $4.43M 10-Q · filed 2017-02-09 |
| 2016-09-30 | -$679.21K 10-K · filed 2018-12-19 | -$956.07K 10-K · filed 2016-12-15 |
| 2016-06-30 | -$3.77M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$2.94M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.53M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$4.76M 10-K · filed 2017-12-29 | -$5.23M 10-K · filed 2015-12-11 |
| 2015-06-30 | $3.93M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $343.06K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $11.84M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $10.78M 10-K/A · filed 2017-12-11 | $10.44M 10-K · filed 2014-12-23 |
| 2014-06-30 | $15.04M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $7.36M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $15.11M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $6.70M 10-K/A · filed 2017-12-11 | |
| 2013-06-30 | $7.80M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $11.55M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $11.62M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $7.03M 10-K · filed 2015-12-11 | |
| 2012-06-30 | $9.01M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $6.24M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $8.11M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $9.08M 10-K · filed 2014-12-23 | |
| 2011-06-30 | $9.18M 10-Q · filed 2011-08-09 | |
| 2010-09-30 | $27.85M 10-K · filed 2013-12-27 | |
| 2009-09-30 | $8.84M 10-K · filed 2012-12-14 | |
| 2008-09-30 | $10.84M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |